Table 2.
Growth factors and tumour oncogenes/suppressors modulating macropinocytosis.
protein | activity in macropinocytosis | associated cancer | reference |
---|---|---|---|
Ras | membrane ruffling, macropinosome formation and trafficking | pancreas, biliary tract, large intestine, small intestine, lung, ovary | reviewed in Prior et al. [78] |
Rac1 | membrane ruffling | skin melanomas | Krauthammer et al. [79] |
PI3 K | membrane ruffle extension, macropinosome formation | large intestine, central nervous system, gastric, breast, endometrium, lung, head and neck cancers |
Samuels et al. [80] Bauer et al. [81] |
PTEN | PI3 signalling pathway antagonist | endometrium, brain, skin, prostate | reviewed in Bauer et al. [81] |
neurofibromin (NF1) | RasGAP/Ras inhibitor | neurofibromatosis type 1 | Bloomfield et al. [82] |
EGF/EGFR | MP initiation | lung, colon, breast, ovary, brain, head and neck | reviewed in Normanno et al. [83] |
CXCL12/CXCR4 | MP initiation | pituitary tumour, familial chronic lymphocytic leukaemia, breast, gastric, pancreas, ovary, colon | reviewed in Guo et al. [84] |